JNM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH RSS TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Figures Only
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Tzen, K.-Y.
Right arrow Articles by Ting, G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Tzen, K.-Y.
Right arrow Articles by Ting, G.
Journal of Nuclear Medicine Vol. 42 No. 3 408-413
© 2001 by Society of Nuclear Medicine


CLINICAL INVESTIGATIONS

Differential Diagnosis of Parkinson’s Disease and Vascular Parkinsonism by 99mTc-TRODAT-1

Kai-Yuan Tzen, Chin-Song Lu, Tzu-Chen Yen, Shiaw-Pyng Wey and Gann Ting

Departments of Nuclear Medicine and Neurology, Chang Gung Memorial Hospital at Lin-Ko and Keelung, Taipei Medical Center and School of Medicine, Chang Gung University; and Institute of Nuclear Energy Research, Lung-Tan, Taiwan

The aim of this study was to use brain SPECT to differentiate vascular parkinsonism (VP) from Parkinson’s disease. Methods: Fourteen VP patients (age range, 59–87 y; mean age, 70 ± 7.5 y), 30 Parkinson’s disease patients (age range, 54–84 y; mean age, 65 ± 8.8 y), and 26 healthy (control) individuals (age range, 50–85 y; mean age, 60 ± 9 y) were examined. A 925-MBq (25 mCi) dose of 99mTc-TRODAT-1 was injected intravenously, and brain SPECT images were acquired 4 h after injection. The ratio of specific to nonspecific striatal 99mTc-TRODAT-1 binding was measured and compared. Results: After a region-of-interest analysis of the images from VP patients, Parkinson’s disease patients, and healthy volunteers was performed to obtain ratios of putamen to occipital and striatal to occipital binding as a measurement of specific binding to the dopamine transporters in these regions of the brain, where dopamine neurons are concentrated, the specific binding in the 14 VP patients was slightly lower than but not statistically different from that of the healthy individuals in both putamen and caudate areas. A significant decrease in uptake of 99mTc-TRODAT-1 in the striatum (P < 0.01) was found in Parkinson’s disease patients. Reduction of the uptake was more pronounced in the contralateral putamen of Parkinson’s disease patients than that of VP patients (P < 0.001). A significant bilateral striatal asymmetry was also observed in Parkinson’s disease patients but not in VP patients (P < 0.01). Conclusion: Our findings clearly show that, for VP patients, 99mTc-TRODAT-1 SPECT is a reliable method to differentiate VP from Parkinson’s disease. Further studies, including those to differentiate Parkinson’s disease from arteriosclerotic parkinsonism and patients with both VP and Parkinson’s disease, are needed to help rule out the possibility of Parkinson’s disease as early as possible.

Key Words: Parkinson’s disease • vascular parkinsonism • 99mTc-TRODAT-1




This article has been cited by other articles:


Home page
J. Neurol. Neurosurg. PsychiatryHome page
G Kagi, K P Bhatia, and E Tolosa
The role of DAT-SPECT in movement disorders
J. Neurol. Neurosurg. Psychiatry, January 1, 2010; 81(1): 5 - 12.
[Abstract] [Full Text] [PDF]


Home page
JNMHome page
R. Ter-Antonyan, R. J. Jaszczak, K. L. Greer, J. E. Bowsher, S. D. Metzler, and R. E. Coleman
Combination of Converging Collimators for High-Sensitivity Brain SPECT
J. Nucl. Med., September 1, 2009; 50(9): 1548 - 1556.
[Abstract] [Full Text] [PDF]


Home page
JNMHome page
M. Lorberboym, R. Djaldetti, E. Melamed, M. Sadeh, and Y. Lampl
123I-FP-CIT SPECT Imaging of Dopamine Transporters in Patients with Cerebrovascular Disease and Clinical Diagnosis of Vascular Parkinsonism
J. Nucl. Med., October 1, 2004; 45(10): 1688 - 1693.
[Abstract] [Full Text] [PDF]


Home page
JNMHome page
Y.-H. Weng, T.-C. Yen, M.-C. Chen, P.-F. Kao, K.-Y. Tzen, R.-S. Chen, S.-P. Wey, G. Ting, and C.-S. Lu
Sensitivity and Specificity of 99mTc-TRODAT-1 SPECT Imaging in Differentiating Patients with Idiopathic Parkinson's Disease from Healthy Subjects
J. Nucl. Med., March 1, 2004; 45(3): 393 - 401.
[Abstract] [Full Text]


Home page
JNMHome page
C.-S. Lu, Y.-H. Weng, M.-C. Chen, R.-S. Chen, K.-Y. Tzen, S.-P. Wey, G. Ting, H.-C. Chang, and T.-C. Yen
99mTc-TRODAT-1 Imaging of Multiple System Atrophy
J. Nucl. Med., January 1, 2004; 45(1): 49 - 55.
[Abstract] [Full Text] [PDF]


Home page
JNMHome page
T.-C. Yen, K.-Y. Tzen, M.-C. Chen, Y.-H. W. Chou, R.-S. Chen, C.-J. Chen, S.-P. Wey, G. Ting, and C.-S. Lu
Dopamine Transporter Concentration Is Reduced in Asymptomatic Machado-Joseph Disease Gene Carriers
J. Nucl. Med., February 1, 2002; 43(2): 153 - 159.
[Abstract] [Full Text] [PDF]


Home page
JNMHome page
W.-S. Huang, S.-Z. Lin, J.-C. Lin, S.-P. Wey, G. Ting, and R.-S. Liu
Evaluation of Early-Stage Parkinson's Disease with 99mTc-TRODAT-1 Imaging
J. Nucl. Med., September 1, 2001; 42(9): 1303 - 1308.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH RSS TABLE OF CONTENTS
JOURNAL OF NUCLEAR MEDICINE TECHNOLOGY THE JOURNAL OF NUCLEAR MEDICINE
Copyright © 2001 by the Society of Nuclear Medicine.